Guardant Health
GH
#1635
Rank
HK$103.34 B
Marketcap
HK$795.76
Share price
3.55%
Change (1 day)
114.71%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Earnings for Guardant Health (GH)

Earnings in 2025 (TTM): -HK$3.1 Billion

According to Guardant Health 's latest financial reports the company's current earnings are HK$0.90 Billion. In 2024 the company made an earning of -HK$3.4 Billion, an increase over its 2023 earnings that were of -HK$3.75 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Guardant Health from 2018 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$3.1 Billion-8.85%
2024 -HK$3.4 Billion-9.12%
2023 -HK$3.75 Billion-26.73%
2022 -HK$5.11 Billion69.96%
2021 -HK$3.01 Billion56.35%
2020 -HK$1.93 Billion252.69%
2019 -HK$0.55 Billion-17.22%
2018 -HK$0.66 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Neogen
NEOG
-HK$4.83 Billion 55.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
-HK$2.43 Billion-22.06%๐Ÿ‡บ๐Ÿ‡ธ USA